Globally 325 million people are living with hepatitis B and hepatitis C but, despite the fact that the solutions to eliminate these infectious diseases exist, efforts to implement them at scale are only just beginning. Many countries now have or are developing national plans but funding for these is proving to be a significant barrier.

Countries faced with the challenge of how to fund their national viral hepatitis programme may want to consider this within the framework of Universal Health Coverage and extend their current coverage to include hepatitis, reach those not currently covered and reduce cost sharing and fees to the patient.